Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.260
-0.070 (-3.00%)
At close: Mar 11, 2025, 4:00 PM
2.214
-0.046 (-2.06%)
After-hours: Mar 11, 2025, 7:50 PM EST

Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $166.41 million as of March 11, 2025. Its market cap has increased by 59.55% in one year.

Market Cap
166.41M
Enterprise Value
144.69M
1-Year Change
59.55%
Ranking
Category
Stock Price
$2.26

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $166.41M, an increase of 1,310.27%. That is a compound annual growth rate of 10.59%.

History

DateMarket Cap% Change
Mar 10, 2025171.60M23.99%
Dec 31, 2024138.40M6.54%
Dec 29, 2023129.90M87.18%
Dec 30, 202269.40M83.11%
Dec 31, 202137.90M-68.68%
Dec 31, 2020121.00M148.46%
Dec 31, 201948.70M5.64%
Dec 31, 201846.10M-50.11%
Dec 29, 201792.40M107.64%
Dec 30, 201644.50M-56.29%
Dec 31, 2015101.80M-40.95%
Dec 31, 2014172.40M-52.64%
Dec 31, 2013364.00M-24.96%
Dec 31, 2012485.10M14.93%
Dec 30, 2011422.10M-47.92%
Dec 31, 2010810.50M58.46%
Dec 31, 2009511.50M266.14%
Dec 31, 2008139.70M-45.71%
Dec 31, 2007257.30M2,552.58%
Dec 29, 20069.70M-21.77%
Dec 30, 200512.40M1,671.43%
Dec 31, 2004700.00K-41.67%
Dec 31, 20031.20M300.00%
Dec 31, 2002300.00K-57.14%
Dec 31, 2001700.00K-
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition